Evidence map›Paper›PMID 20683549›Full record

ReviewMolecular medicine (Cambridge, Mass.)

Interleukin-1β and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritis.

Gianfranco Ferraccioli, Luisa Bracci-Laudiero, Stefano Alivernini, Elisa Gremese, Barbara Tolusso, Fabrizio De Benedetti

Open access · goldAbstract readReview
In one paragraph

Review in Molecular medicine (Cambridge, Mass.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 109 citations in OpenAlex.

  1. Article
  2. Effect ofOpen veterinary journal · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Comparative Chemical Analysis of EightAntioxidants (Basel, Switzerland) · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Effects of Essential Oils-Based Supplement andAnimals : an open access journal from MDPI · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Gianfranco FerraccioliDivision of Rheumatology, School of Medicine, Catholic University of the Sacred Heart, Rome, Italy. gf.ferraccioli@rm.unicatt.it
Luisa Bracci-Laudiero
Stefano Alivernini
Elisa Gremese
Barbara Tolusso
Fabrizio De Benedetti
Università Cattolica del Sacro Cuore · ITInstitute of Neurobiology and Molecular Medicine · ITUniversity of the Sacred Heart · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor necrosis factor-α (TNF-α) is the major target of the therapeutic approach in rheumatoid arthritis. A key issue in the approach to chronic arthritis is the understanding of the crucial molecules driving the transition from the acute phase to the chronic irreversible phase of the disease. In this review we analyzed five experimental arthritis animal models (antigen-induced arthritis, adjuvant-induced arthritis, streptococcal cell wall arthritis, collagen-induced arthritis and SKG) considered as possible scenarios to facilitate interpretation of the biology of human rheumatoid arthritis. The SKG model is strictly dependent on interleukin (IL)-6. In the other models, IL-1β and IL-6, more than TNF-α, appear to be relevant in driving the transition, which suggests that these should be the targets of an early intervention to stop the course toward the chronic form of the disease.

Indexed as

InflammationAnimalsArthritis, ExperimentalArthritis, InfectiousArthritis, RheumatoidChronic DiseaseDisease Models, AnimalHumansInterleukin-1betaInterleukin-6MiceMice, Inbred BALB CTumor Necrosis Factor-alphaInterleukin-1betaInterleukin-6Tumor Necrosis Factor-alpha

Identifiers

PMID20683549
PMCPMC2972398
OpenAlexW126724734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.